López, M. R. and Suarez, M. C. (2020) “Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: ‘Short-term emicizumab in patients with acquired hemophilia A’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301818.